Skip to content

In Vitro Fertilization

Evaluation of the Effect of Melatonin on In Vitro Fertilization (IVF) in Women with Poly Cystic Ovarian

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151123025202N11
Enrollment
320
Registered
2020-06-30
Start date
2020-07-22
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility due to polycystic ovary syndrome. Female infertility, unspecified

Interventions

Intervention 1: Intervention group: After initial evaluations by a physician and doing uterine and ovarian ultrasounds on days 1 to 3 of the menstrual cycle will be treated with metformin plus melaton

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 40 Years

Inclusion criteria

Inclusion criteria: Age <40 years No Symptoms of hyperendrogenism Abnormal menstrual cycles Use IVF assisted reproductive techniques for the first or second time No fertility problems in the patient's spouse Natural uterine cavity according to hysterosalpingography result

Exclusion criteria

Exclusion criteria: Presence of underlying disease Drug Interactions Use of hormonal drugs in the last three months Inadequate ovarian response defects

Design outcomes

Primary

MeasureTime frame
Chemical pregnancy. Timepoint: 14 day after intra uterine insemination. Method of measurement: B_HCG.

Secondary

MeasureTime frame
Clinical Pregnancy. Timepoint: 6 and 20 weeks after B-HCG positive. Method of measurement: sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Moradi

Hamedan University of Medical Sciences

a.moradi@umsha.ac.ir+98 81 3838 0097

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026